Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)Disease (CONTEST)
A Multi-center Phase II Randomized Study of Customized Neoadjuvant Therapy Versus Standard Chemotherapy in Non-small Cell Lung Cancer (NSLC) Patients With Resectable Stage IIIA (N2) Disease (CONTEST-TRIAL)
Sponsor: ASL TO4, Chivasso
Listed as NCT01784549, this PHASE2 trial focuses on Non Small Cell Lung Cancer and remains ongoing. Sponsored by ASL TO4, Chivasso, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Mar 2026 — Present [monthly]
Unknown PHASE2
-
Sep 2024 — Mar 2026 [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Jan 2019 — Jan 2021 [monthly]
Unknown Status PHASE2
▶ Show 3 earlier versions
-
Jul 2018 — Jan 2019 [monthly]
Unknown Status PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Unknown Status PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE2
First recorded
Jul 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ASL TO4, Chivasso
- Azienda Ospedaliera S. Maria della Misericordia
- Azienda Ospedaliera San Camillo Forlanini
- Azienda Ospedaliera San Gerardo di Monza
- Azienda Ospedaliera San Giovanni Battista
- Azienda Ospedaliera Sant'Andrea
- Azienda Ospedaliera Santa Maria Degli Angeli
- Azienda Ospedaliera Spedali Riuniti di Livorno, Livorno
- Azienda Ospedaliera Universitaria Integrata Verona
- Azienda Ospedaliera dei Colli Monaldi-Cotugno-CTO, Napoli
- Azienda Ospedaliera, Ospedale Civile di Legnano
- Azienda Sanitaria Locale di Cagliari
- Azienda Sanitaria Locale n.2 Savonese
- Azienda Sanitaria Universitaria Integrata del Trentino
- IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
- Istituto Clinico Humanitas
- Istituto Tumori Giovanni Paolo II, BARI
- Ospedale Santa Croce-Carle Cuneo
For direct contact, visit the study record on ClinicalTrials.gov .